206 related articles for article (PubMed ID: 36607090)
1. Effect of nano-curcumin on various diseases: A comprehensive review of clinical trials.
Hassanizadeh S; Shojaei M; Bagherniya M; Orekhov AN; Sahebkar A
Biofactors; 2023; 49(3):512-533. PubMed ID: 36607090
[TBL] [Abstract][Full Text] [Related]
2. Curcumin nanoparticles and the therapeutic potential of curcumin for musculoskeletal disorders.
Wu HY; Yu HT; Kang B; Xuan YY; Zhang HQ; Li XS
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(20):9680-9702. PubMed ID: 37916332
[TBL] [Abstract][Full Text] [Related]
3. Curcumin-piperine co-supplementation and human health: A comprehensive review of preclinical and clinical studies.
Heidari H; Bagherniya M; Majeed M; Sathyapalan T; Jamialahmadi T; Sahebkar A
Phytother Res; 2023 Apr; 37(4):1462-1487. PubMed ID: 36720711
[TBL] [Abstract][Full Text] [Related]
4. The effectiveness of nano-curcumin on patients with COVID-19: A systematic review of clinical trials.
Shojaei M; Foshati S; Abdi M; Askari G; Sukhorukov VN; Bagherniya M; Sahebkar A
Phytother Res; 2023 Apr; 37(4):1663-1677. PubMed ID: 36799442
[TBL] [Abstract][Full Text] [Related]
5. The Multifaceted Role of Curcumin in Advanced Nanocurcumin Form in the Treatment and Management of Chronic Disorders.
Tagde P; Tagde P; Islam F; Tagde S; Shah M; Hussain ZD; Rahman MH; Najda A; Alanazi IS; Germoush MO; Mohamed HRH; Algandaby MM; Nasrullah MZ; Kot N; Abdel-Daim MM
Molecules; 2021 Nov; 26(23):. PubMed ID: 34885693
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological properties and underlying mechanisms of curcumin and prospects in medicinal potential.
Fu YS; Chen TH; Weng L; Huang L; Lai D; Weng CF
Biomed Pharmacother; 2021 Sep; 141():111888. PubMed ID: 34237598
[TBL] [Abstract][Full Text] [Related]
7. The golden spice curcumin in cancer: A perspective on finalized clinical trials during the last 10 years.
Karaboga Arslan AK; Uzunhisarcıklı E; Yerer MB; Bishayee A
J Cancer Res Ther; 2022; 18(1):19-26. PubMed ID: 35381757
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research.
Jurenka JS
Altern Med Rev; 2009 Jun; 14(2):141-53. PubMed ID: 19594223
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Nanocurcumin as an Add-On Treatment for Patients Hospitalized with COVID-19: A Double-Blind, Randomized Clinical Trial.
Ahmadi S; Mehrabi Z; Zare M; Ghadir S; Masoumi SJ
Int J Clin Pract; 2023; 2023():5734675. PubMed ID: 37547100
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in curcumin nanoformulation for cancer therapy.
Lee WH; Loo CY; Young PM; Traini D; Mason RS; Rohanizadeh R
Expert Opin Drug Deliv; 2014 Aug; 11(8):1183-201. PubMed ID: 24857605
[TBL] [Abstract][Full Text] [Related]
11. A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents.
Razavi BM; Ghasemzadeh Rahbardar M; Hosseinzadeh H
Phytother Res; 2021 Dec; 35(12):6489-6513. PubMed ID: 34312922
[TBL] [Abstract][Full Text] [Related]
12. Relevance of the anti-inflammatory properties of curcumin in neurodegenerative diseases and depression.
Tizabi Y; Hurley LL; Qualls Z; Akinfiresoye L
Molecules; 2014 Dec; 19(12):20864-79. PubMed ID: 25514226
[TBL] [Abstract][Full Text] [Related]
13. The clinical use of curcumin on neurological disorders: An updated systematic review of clinical trials.
Mohseni M; Sahebkar A; Askari G; Johnston TP; Alikiaii B; Bagherniya M
Phytother Res; 2021 Dec; 35(12):6862-6882. PubMed ID: 34528307
[TBL] [Abstract][Full Text] [Related]
14. Current clinical developments in curcumin-based therapeutics for cancer and chronic diseases.
Kumar A; Harsha C; Parama D; Girisa S; Daimary UD; Mao X; Kunnumakkara AB
Phytother Res; 2021 Dec; 35(12):6768-6801. PubMed ID: 34498308
[TBL] [Abstract][Full Text] [Related]
15. A Systematic Review of the Clinical Use of Curcumin for the Treatment of Osteoarthritis.
Shokri-Mashhadi N; Bagherniya M; Askari G; Sathyapalan T; Sahebkar A
Adv Exp Med Biol; 2021; 1291():265-282. PubMed ID: 34331696
[TBL] [Abstract][Full Text] [Related]
16. Bringing Curcumin to the Clinic in Cancer Prevention: a Review of Strategies to Enhance Bioavailability and Efficacy.
Mahran RI; Hagras MM; Sun D; Brenner DE
AAPS J; 2017 Jan; 19(1):54-81. PubMed ID: 27783266
[TBL] [Abstract][Full Text] [Related]
17. Curcumin: therapeutical potential in ophthalmology.
Pescosolido N; Giannotti R; Plateroti AM; Pascarella A; Nebbioso M
Planta Med; 2014 Mar; 80(4):249-54. PubMed ID: 24323538
[TBL] [Abstract][Full Text] [Related]
18. Antiinflammatory potential of nano-curcumin as an alternative therapeutic agent for the treatment of mild-to-moderate hospitalized COVID-19 patients in a placebo-controlled clinical trial.
Asadirad A; Nashibi R; Khodadadi A; Ghadiri AA; Sadeghi M; Aminian A; Dehnavi S
Phytother Res; 2022 Feb; 36(2):1023-1031. PubMed ID: 35040210
[TBL] [Abstract][Full Text] [Related]
19. Curcumin nanoformulations to combat aging-related diseases.
Mahjoob M; Stochaj U
Ageing Res Rev; 2021 Aug; 69():101364. PubMed ID: 34000462
[TBL] [Abstract][Full Text] [Related]
20. Nanotechnology-applied curcumin for different diseases therapy.
Ghalandarlaki N; Alizadeh AM; Ashkani-Esfahani S
Biomed Res Int; 2014; 2014():394264. PubMed ID: 24995293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
